Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Colombo

Showing results (111-120 of 134) with videos related to

Pageof 14
Sort By:
The Journal of Headache and Pain|September 1, 2019
Current and emerging evidence-based treatment options in chronic migraine: a narrative reviewElio Clemente Agostoni, Piero Barbanti, Paolo Calabresi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 12, 2014
Familial clustering in Italian progressive-onset and bout-onset multiple sclerosisClara Guaschino, Federica Esposito, Giuseppe Liberatore, et al.
Journal of Neurology|August 7, 2023
The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN)Massimo Filippi, Roberta Messina, Marta Bartezaghi, et al.
Neuroscience Letters|November 24, 2011
MicroRNA and mRNA expression profile screening in multiple sclerosis patients to unravel novel pathogenic steps and identify potential biomarkersFilippo Martinelli-Boneschi, Chiara Fenoglio, Paola Brambilla, et al.
The Journal of Headache and Pain|March 23, 2023
Early and sustained efficacy of fremanezumab over 24-weeks in migraine patients with multiple preventive treatment failures: the multicenter, prospective, real-life FRIEND2 studyPiero Barbanti, Gabriella Egeo, Cinzia Aurilia, et al.
European Journal of Neurology|November 26, 2021
Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3-month observational, longitudinal, cohort, multicenter, Italian real-life studyFabrizio Vernieri, Claudia Altamura, Nicoletta Brunelli, et al.
Neuroscience Letters|October 17, 2012
Association between DPP6 polymorphism and the risk of progressive multiple sclerosis in Northern and Southern EuropeansPaola Brambilla, Federica Esposito, Eva Lindstrom, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 30, 2012
A genome-wide association study in progressive multiple sclerosisFilippo Martinelli-Boneschi, Federica Esposito, Paola Brambilla, et al.
Brain, Behavior, and Immunity|August 3, 2024
Machine learning-driven diagnosis of multiple sclerosis from whole blood transcriptomicsMaryam Omrani, Rosaria Rita Chiarelli, Massimo Acquaviva, et al.
Headache|December 6, 2017
Clinical Features, Familial History, and Migraine Precursors in Patients With Definite Vestibular Migraine: The VM-Phenotypes ProjectsRoberto Teggi, Bruno Colombo, Roberto Albera, et al.
Pageof 14

Showing results (111-120 of 134) with videos related to

Sort By:
Pageof 14
The Journal of Headache and Pain|September 1, 2019
Current and emerging evidence-based treatment options in chronic migraine: a narrative reviewElio Clemente Agostoni, Piero Barbanti, Paolo Calabresi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 12, 2014
Familial clustering in Italian progressive-onset and bout-onset multiple sclerosisClara Guaschino, Federica Esposito, Giuseppe Liberatore, et al.
Journal of Neurology|August 7, 2023
The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN)Massimo Filippi, Roberta Messina, Marta Bartezaghi, et al.
Neuroscience Letters|November 24, 2011
MicroRNA and mRNA expression profile screening in multiple sclerosis patients to unravel novel pathogenic steps and identify potential biomarkersFilippo Martinelli-Boneschi, Chiara Fenoglio, Paola Brambilla, et al.
The Journal of Headache and Pain|March 23, 2023
Early and sustained efficacy of fremanezumab over 24-weeks in migraine patients with multiple preventive treatment failures: the multicenter, prospective, real-life FRIEND2 studyPiero Barbanti, Gabriella Egeo, Cinzia Aurilia, et al.
European Journal of Neurology|November 26, 2021
Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3-month observational, longitudinal, cohort, multicenter, Italian real-life studyFabrizio Vernieri, Claudia Altamura, Nicoletta Brunelli, et al.
Neuroscience Letters|October 17, 2012
Association between DPP6 polymorphism and the risk of progressive multiple sclerosis in Northern and Southern EuropeansPaola Brambilla, Federica Esposito, Eva Lindstrom, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 30, 2012
A genome-wide association study in progressive multiple sclerosisFilippo Martinelli-Boneschi, Federica Esposito, Paola Brambilla, et al.
Brain, Behavior, and Immunity|August 3, 2024
Machine learning-driven diagnosis of multiple sclerosis from whole blood transcriptomicsMaryam Omrani, Rosaria Rita Chiarelli, Massimo Acquaviva, et al.
Headache|December 6, 2017
Clinical Features, Familial History, and Migraine Precursors in Patients With Definite Vestibular Migraine: The VM-Phenotypes ProjectsRoberto Teggi, Bruno Colombo, Roberto Albera, et al.
Pageof 14